Revalesio Corporation
Get Full AccessDescription
- Revalesio Corporation is a pioneering clinical stage biomedical company focused on the development of a new class of anti-inflammatory therapeutics. Revalesio initiated the development of its unique charge-stabilized nanostructure (CSN) platform in 2006 and is currently in clinical trials with its lead product candidate RNS60.
-
Headquarters:1202 East D Street , Tacoma, Washington, United States
More -
Phone Number: +1 253-922-2600
-
Website: https://www.revalesio.com
-
Employees:18
-
Revenue:$1 - 10M
-
Legal Name:Revalesio Corporation
-
Revalesio Corporation's Social Media
-
Is this data correct?
-
| NAICS Code: 339999 |
Show More
Frequently Asked Questions regarding Revalesio Corporation
-
Where are Revalesio Corporation's Headquarters?
Revalesio Corporation's Headquarters are in 1202 East D Street ,Tacoma,Washington,United States
-
What is Revalesio Corporation's phone number?
Revalesio Corporation's phone number is +1 253-922-2600
-
What is Revalesio Corporation's official website?
Revalesio Corporation's official website is https://www.revalesio.com
-
What is Revalesio Corporation's Revenue?
Revalesio Corporation's revenue is $1 - 10M
-
What is Revalesio Corporation's NAICS code?
Revalesio Corporation's NAICS code is 339999
-
How many employees are working in Revalesio Corporation
Revalesio Corporation has 18 employees
-
What is Revalesio Corporation's Industry?
Revalesio Corporation is in the industry of Pharmaceuticals
-
Who is Revalesio Corporation's President?
Revalesio Corporation's President is Greg Archambeau

